These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 22071839)

  • 1. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).
    James S; Montgomery P; Williams K
    Cochrane Database Syst Rev; 2011 Nov; (11):CD007992. PubMed ID: 22071839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochrane review: social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).
    Reichow B; Steiner AM; Volkmar F
    Evid Based Child Health; 2013 Mar; 8(2):266-315. PubMed ID: 23877884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acupuncture for autism spectrum disorders (ASD).
    Cheuk DK; Wong V; Chen WX
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD007849. PubMed ID: 21901712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).
    Reichow B; Steiner AM; Volkmar F
    Cochrane Database Syst Rev; 2012 Jul; (7):CD008511. PubMed ID: 22786515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parent-mediated early intervention for young children with autism spectrum disorders (ASD).
    Oono IP; Honey EJ; McConachie H
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009774. PubMed ID: 23633377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.
    Mazahery H; Stonehouse W; Delshad M; Kruger MC; Conlon CA; Beck KL; von Hurst PR
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD).
    Reichow B; Barton EE; Boyd BA; Hume K
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009260. PubMed ID: 23076956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids for bipolar disorder.
    Montgomery P; Richardson AJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005169. PubMed ID: 18425912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.
    Hurwitz R; Blackmore R; Hazell P; Williams K; Woolfenden S
    Cochrane Database Syst Rev; 2012 Mar; (3):CD008372. PubMed ID: 22419332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ω-3 and ω-6 Fatty Acid Supplementation May Reduce Autism Symptoms Based on Parent Report in Preterm Toddlers.
    Keim SA; Gracious B; Boone KM; Klebanoff MA; Rogers LK; Rausch J; Coury DL; Sheppard KW; Husk J; Rhoda DA
    J Nutr; 2018 Feb; 148(2):227-235. PubMed ID: 29490101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders.
    Tan ML; Ho JJ; Teh KH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009398. PubMed ID: 23235675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole for autism spectrum disorders (ASD).
    Ching H; Pringsheim T
    Cochrane Database Syst Rev; 2012 May; (5):CD009043. PubMed ID: 22592735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ω-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis.
    Horvath A; Łukasik J; Szajewska H
    J Nutr; 2017 Mar; 147(3):367-376. PubMed ID: 28077731
    [No Abstract]   [Full Text] [Related]  

  • 15. Omega-3 fatty acids for intermittent claudication.
    Campbell A; Price J; Hiatt WR
    Cochrane Database Syst Rev; 2013 Jul; (7):CD003833. PubMed ID: 23824785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelation for autism spectrum disorder (ASD).
    James S; Stevenson SW; Silove N; Williams K
    Cochrane Database Syst Rev; 2015 May; (5):CD010766. PubMed ID: 26106752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acids for intermittent claudication.
    Sommerfield T; Price J; Hiatt WR
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003833. PubMed ID: 17943801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials.
    Cheng YS; Tseng PT; Chen YW; Stubbs B; Yang WC; Chen TY; Wu CK; Lin PY
    Neuropsychiatr Dis Treat; 2017; 13():2531-2543. PubMed ID: 29042783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acids for cystic fibrosis.
    Oliver C; Jahnke N
    Cochrane Database Syst Rev; 2011 Aug; (8):CD002201. PubMed ID: 21833942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.